UCLA Hospital

Urinary Bladder Cancer in African Americans

Dr. Wu’s study is called the University of California Minority Patient-Derived Xenograft Trial and Development Center (UCaMP). The UCaMP study will examine treatment options by looking at cells from patients with bladder cancer including African-Americans.